Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial

de Tute, R.M., Cook, G. orcid.org/0000-0001-7196-7364, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation, 59. pp. 431-434. ISSN 0268-3369

Metadata

Item Type: Article
Authors/Creators:
Dates:
  • Published: March 2024
  • Published (online): 9 January 2024
  • Accepted: 27 November 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > School of Medicine - Dean's Office (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
C18803/A7264
Chugai Pharma UK Ltd
NONE GIVEN
Depositing User: Symplectic Publications
Date Deposited: 15 Jan 2025 13:23
Last Modified: 15 Jan 2025 13:23
Status: Published
Publisher: Springer Nature
Identification Number: 10.1038/s41409-023-02164-4
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)